Transdermal “Natural GLP-1” Dietary Supplements Violate Law and Place Patients at Risk

View at publisher
Authors: C. Michael White, Zeeya Tai, Klaus Nuzi
Cited by: 0
References: 15

Abstract

Consumers precluded from obtaining semaglutide or tirzepatide by clinicians or insurers are turning to natural "GLP-1" transdermal patches. The Dietary Supplement Health and Education Act specifies dietary supplement products must be swallowed, so all these products are illegal. We identified 24 transdermal patch dietary supplement products and 1 transdermal gel product with an average of 7 ± 4 natural ingredients (berberine, glutamine/glutamate, cinnamon, and pomegranate most listed). No certificates of analysis were posted, many products lacked the Food and Drug Administration disclaimer, and many products used deceptive advertising. Several products had 1- to 2-star reviews and consumer comments suggesting lack of efficacy or adverse events.

Fields of Study & Subjects

Complementary and Alternative Medicine Studies Pharmacology and Obesity Treatment Pharmaceutical studies and practices

Publication details

Journal / source
Annals of Pharmacotherapy
Volume
60
Issue
8
Pages
813–816
Publication date
2 January 2026
Language
EN